Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Liver Failure, Acute | 5 | 2020 | 279 | 2.90 | Why? |
| Hepatitis B virus | 3 | 2019 | 882 | 1.30 | Why? |
| Hepatitis B Antibodies | 2 | 2017 | 142 | 1.27 | Why? |
| Hepatitis B | 3 | 2019 | 888 | 1.17 | Why? |
| DNA, Viral | 4 | 2021 | 2521 | 1.08 | Why? |
| Hepatitis B Core Antigens | 1 | 2017 | 76 | 0.67 | Why? |
| Bilirubin | 1 | 2020 | 503 | 0.67 | Why? |
| Transferrin | 1 | 2017 | 90 | 0.66 | Why? |
| Thinness | 1 | 2017 | 99 | 0.65 | Why? |
| Polycystic Ovary Syndrome | 1 | 2017 | 151 | 0.56 | Why? |
| Virus Activation | 1 | 2019 | 480 | 0.56 | Why? |
| Androgens | 1 | 2017 | 267 | 0.54 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.53 | Why? |
| Hepatitis, Autoimmune | 1 | 2018 | 254 | 0.53 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.52 | Why? |
| Molecular Diagnostic Techniques | 3 | 2021 | 4239 | 0.40 | Why? |
| Ferritins | 1 | 2017 | 2055 | 0.35 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.32 | Why? |
| Germany | 6 | 2021 | 9196 | 0.25 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.24 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.24 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.23 | Why? |
| BK Virus | 2 | 2018 | 135 | 0.21 | Why? |
| Genome, Viral | 2 | 2019 | 13157 | 0.20 | Why? |
| Kidney Transplantation | 5 | 2021 | 5397 | 0.20 | Why? |
| Polyomavirus Infections | 2 | 2018 | 156 | 0.20 | Why? |
| Sequence Analysis, DNA | 2 | 2019 | 2830 | 0.19 | Why? |
| Hepatitis B Surface Antigens | 1 | 2019 | 305 | 0.17 | Why? |
| Menstrual Cycle | 1 | 2017 | 59 | 0.17 | Why? |
| RNA, Untranslated | 1 | 2018 | 140 | 0.17 | Why? |
| Trans-Activators | 1 | 2018 | 170 | 0.17 | Why? |
| Lipoproteins | 1 | 2018 | 240 | 0.17 | Why? |
| Remission, Spontaneous | 1 | 2017 | 186 | 0.16 | Why? |
| Glucose Tolerance Test | 1 | 2017 | 238 | 0.16 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2018 | 385 | 0.15 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.15 | Why? |
| Transplantation, Homologous | 1 | 2018 | 757 | 0.14 | Why? |
| Mutation | 3 | 2019 | 12376 | 0.13 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.13 | Why? |
| Adult | 13 | 2021 | 244371 | 0.12 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.12 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.12 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.10 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.10 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.10 | Why? |
| Metformin | 1 | 2017 | 640 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Female | 13 | 2021 | 380317 | 0.10 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.10 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.09 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.09 | Why? |
| Hospitals, University | 2 | 2021 | 4173 | 0.09 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.09 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.09 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.09 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.09 | Why? |
| Male | 12 | 2021 | 367725 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| Viral Load | 2 | 2019 | 15850 | 0.08 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.08 | Why? |
| Tumor Virus Infections | 2 | 2018 | 127 | 0.08 | Why? |
| Humans | 20 | 2021 | 930598 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.08 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.08 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.08 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.07 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Aged | 8 | 2021 | 215776 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.06 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.06 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Transplantation Immunology | 1 | 2021 | 99 | 0.05 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.05 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.05 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Cyclosporins | 1 | 2018 | 16 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Cytosol | 1 | 2018 | 77 | 0.05 | Why? |
| Diagnostic Tests, Routine | 2 | 2021 | 2643 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Transduction, Genetic | 1 | 2018 | 273 | 0.04 | Why? |
| Protein Isoforms | 1 | 2018 | 347 | 0.04 | Why? |
| Mutant Proteins | 1 | 2018 | 328 | 0.04 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2017 | 177 | 0.04 | Why? |
| Quality Control | 1 | 2021 | 628 | 0.04 | Why? |
| Replicon | 1 | 2018 | 232 | 0.04 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Sirolimus | 1 | 2018 | 240 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Tacrolimus | 1 | 2018 | 435 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Transplant Recipients | 2 | 2021 | 4982 | 0.03 | Why? |
| Causality | 1 | 2017 | 857 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.03 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2021 | 23402 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Anastasiou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_